CNCR
ETF Series Solutions Trust Range Cancer Therapeutics ETF
CNCR
CNCR
Delisted
CNCR was delisted on the 27th of May, 2025.
25 hedge funds and large institutions have $9.54M invested in ETF Series Solutions Trust Range Cancer Therapeutics ETF in 2021 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 10 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
60% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 10
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
25
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$658K | |
| 2 | +$255K | |
| 3 | +$238K | |
| 4 |
PAG
Private Advisor Group
Morristown,
New Jersey
|
+$33.3K |
| 5 |
BBPWM
Blue Bell Private Wealth Management
Blue Bell,
Pennsylvania
|
+$12.6K |
Top Sellers
| 1 | -$1.91M | |
| 2 | -$748K | |
| 3 | -$559K | |
| 4 |
WS
Wedbush Securities
Los Angeles,
California
|
-$202K |
| 5 |
Morgan Stanley
New York
|
-$39.6K |